Search

for
Search:

Sort by

Research

990-1000 / 1000+ results

research Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study

70 citations , February 2018 in “Seminars in Arthritis and Rheumatism”

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

research Efficacy and safety of fremanezumab for migraine prophylaxis in patients with at least three previous preventive failures: Prospective, multicenter, real‐world data from a Greek registry

22 citations , February 2023 in “European Journal of Neurology”

Fremanezumab effectively reduces migraines and improves quality of life with mild side effects.

research Iron and hair loss in women; what is deficiency? This is the real question!

8 citations , February 2007 in “Journal of The American Academy of Dermatology”

Higher serum ferritin levels than currently used might be needed to rule out iron deficiency in women with hair loss.

Self-Healing and Shape-Adaptive Nanocomposite Hydrogels With Anti-Inflammatory, Antioxidant, Antibacterial Activities and Hemostasis for Real-Time Visual Regeneration of Diabetic Wounds

research Self-healing and shape-adaptive nanocomposite hydrogels with anti-inflammatory, antioxidant, antibacterial activities and hemostasis for real-time visual regeneration of diabetic wounds

4 citations , May 2023 in “Composites Part B: Engineering”

The nanocomposite hydrogels can repair themselves, change shape, reduce inflammation, protect against oxidation, kill bacteria, stop bleeding, and help heal diabetic wounds while allowing for wound monitoring.

research Circulating monocytes as a marker of response to adalimumab in patients with hidradenitis suppurativa: A single institution, real-world cohort study

2 citations , September 2024 in “Journal of the American Academy of Dermatology”

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

research Drugs linked to blepharitis, meibomian gland dysfunction, and chalazion: a real-world, population-based pharmacovigilance analysis

1 citations , September 2025 in “Eye”

Certain drugs can cause eyelid inflammation, so doctors should monitor and educate patients on eyelid care.

research Large-Scale, Multicenter, Prospective Registry Study of Ripretinib in Advanced GIST: A Real-World Study from China

1 citations , June 2023 in “Advances in therapy”

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

research Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)

March 2026 in “Figshare”

These medications for BPH have known risks and may have new side effects.

research Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)

March 2026 in “Figshare”

These medications for BPH have known risks and may have new side effects.

research Interest of an anti-hair loss serum containing Silybum marianum extract, manganese pyrrolidone carboxylic acid (PCA), and a Lespedeza capitata extract in the management of post-cancer treatment alopecia: an international real-world study

January 2026 in “EJC Skin Cancer”

The serum effectively improves hair growth and is well-tolerated for post-cancer hair loss.

← Previous page